Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SPARK BIOMEDICAL INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-07-14 to 2025-11-13
Current total value of award: $1149775.19
Description: STTR PHASE 2 TITLED DEVELOPMENT AND TESTING OF A MILITARY-GRADE WEARABLE TRANSCUTANEOUS AURICULAR NEUROSTIMULATION DEVICE TO RESTORE PERFORMANCE AFTER ACUTE STRESS REACTION